What Are the Predictive Factors for Preeclampsia in Oocyte Recipients? - PREROVE

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03668184

Acronym

PREROVE

Enrollment

150

Registered

2018-09-12

Start date

2018-01-02

Completion date

2018-04-27

Last updated

2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oocyte Donation, Pregnancy

Brief summary

The main goal is to determine which risk factors develop preeclampsia in this specific group of oocyte recipients.

Interventions

OTHERpreeclampsia

occurrence of pre-eclampsia

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Inclusion criteria

* All major patients with a pregnancy of more than 22 weeks of amenorrhea resulting from an oocyte donation in one of the study centers, having given birth between January 2010 and April 2017 and not opposed to participation in the study.

Exclusion criteria

* all pregnancies resulting from an oocyte donation abroad, persons of legal age subject to legal protection (safeguard of justice, guardianship, tutorship) and persons deprived of their liberty.

Design outcomes

Primary

Measure	Time frame
occurrence of pre-eclampsia	through study completion, an average of 1 year

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026